My Cart

Cathepsin L

Cathepsin L Overview

English NameCathepsin LApproved Drugs1
Drugs in Clinical Trials0Target SynonymCathepsin L1,CATL,CTSL,MEP,EC:3.4.22.15,CTSL1,Major Excreted Protein,Cathepsin L,FLJ31037
Highest Development StageApproved
English NameCathepsin L
Target SynonymCathepsin L1,CATL,CTSL,MEP,EC:3.4.22.15,CTSL1,Major Excreted Protein,Cathepsin L,FLJ31037
Approved Drugs1
Drugs in Clinical Trials0
Highest Development StageApproved

Cathepsin L Product List

  • Product Category

    Protein (3)

  • Product Status

    Launched (3)

  • Species

    Mouse (1)Human (2)

  • Tag

    His Tag (2)Tag Free (1)

  • Conjugate

    Unconjugated (3)

Cathepsin L Background

Cathepsin L (CTSL1) is also known as major excreted protein (MEP), is a member of the peptidase C1 family, is a dimer composed of disulfide-linked heavy and light chains linked by disulfide bonds. CTSL1 is a lysosomal cysteine proteinase that plays a major role in intracellular protein catabolism. Its substrates include collagen and elastin, as well as alpha-1 protease inhibitor, a major controlling element of neutrophil elastase activity. MEP has been implicated in several pathologic processes, including myofibril necrosis in myopathies and in myocardial ischemia, and in the renal tubular response to proteinuria. CTSL1 is important for the overall degradation of proteins in lysosomes. The specificity of MEP is close to that of papain. As compared to cathepsin B, cathepsin L exhibits higher activity toward protein substrates, but has little activity on Z - Arg – Arg – NHMec, and no peptidyl - dipeptidase activity. Human Cathepsin L activity is greatest under mildly acidic conditions, from pH 4.5 ­ 6.5. The stability of the enzyme decreases at higher pH values

Cathepsin L Synonyms

CTSL1,MEP,CATL,CTSL

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
OlgotrelvirSTI-1558; STI1558ApprovedTexas A&M UniversityOvydso, 奥维宁Mainland ChinaCoronavirus Disease 2019 (COVID-19)Zhejiang Acea Pharmaceutical Co Ltd2025-10-28Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive
Details
  • Overview
  • Product List
  • Marketed Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland